Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | serine/threonine protein kinase | 0.2221 | 0.0037 | 0.0037 |
Echinococcus multilocularis | maternal embryonic leucine zipper kinase | 0.4458 | 0.5056 | 1 |
Loa Loa (eye worm) | CAMK/CAMKL/MELK protein kinase | 0.6662 | 1 | 1 |
Schistosoma mansoni | serine/threonine protein kinase | 0.2221 | 0.0037 | 0.0037 |
Echinococcus multilocularis | serine:threonine protein kinase MARK2 | 0.2221 | 0.0037 | 0.0074 |
Echinococcus granulosus | maternal embryonic leucine zipper kinase | 0.4458 | 0.5056 | 1 |
Echinococcus multilocularis | calcium activated potassium channel | 0.2221 | 0.0037 | 0.0074 |
Trichomonas vaginalis | CAMK family protein kinase | 0.6662 | 1 | 1 |
Schistosoma mansoni | serine/threonine protein kinase | 0.2221 | 0.0037 | 0.0037 |
Schistosoma mansoni | serine/threonine kinase | 0.6662 | 1 | 1 |
Schistosoma mansoni | serine/threonine protein kinase | 0.2221 | 0.0037 | 0.0037 |
Schistosoma mansoni | serine/threonine protein kinase | 0.2221 | 0.0037 | 0.0037 |
Echinococcus multilocularis | serine:threonine protein kinase MARK2 | 0.2221 | 0.0037 | 0.0074 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.